Correlation between the Warburg effect and progression of triple-negative breast cancer

被引:16
作者
Liu, Shaojun [1 ]
Li, Yuxuan [1 ]
Yuan, Meng [1 ]
Song, Qing [1 ]
Liu, Min [1 ]
机构
[1] Nanjing Univ Chinese Med, Dept Oncol, Suzhou TCM Hosp, Suzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 12卷
基金
中国国家自然科学基金;
关键词
Warburg effect; glycolysis; metabolic plasticity; triple-negative breast cancer; basal-like breast cancer; METABOLIC PATHWAYS; CELL COMPETITION; DRUG-RESISTANCE; TUMOR DORMANCY; METASTASIS; MECHANISMS; INHIBITION; PROMOTES; CYCLE; ACTIVATION;
D O I
10.3389/fonc.2022.1060495
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Triple-negative breast cancer (TNBC) is ineligible for hormonal therapy and Her-2-targeted therapy due to the negative expression of the estrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2. Although targeted therapy and immunotherapy have been shown to attenuate the aggressiveness of TNBC partially, few patients have benefited from them. The conventional treatment for TNBC remains chemotherapy. Chemoresistance, however, impedes therapeutic progress over time, and chemotherapy toxicity increases the burden of cancer on patients. Therefore, introducing more advantageous TNBC treatment options is a necessity. Metabolic reprogramming centered on glucose metabolism is considered a hallmark of tumors. It is described as tumor cells tend to convert glucose to lactate even under normoxic conditions, a phenomenon known as the Warburg effect. Similar to Darwinian evolution, its emergence is attributed to the selective pressures formed by the hypoxic microenvironment of pre-malignant lesions. Of note, the Warburg effect does not disappear with changes in the microenvironment after the formation of malignant tumor phenotypes. Instead, it forms a constitutive expression mediated by mutations or epigenetic modifications, providing a robust selective survival advantage for primary and metastatic lesions. Expanding evidence has demonstrated that the Warburg effect mediates multiple invasive behaviors in TNBC, including proliferation, metastasis, recurrence, immune escape, and multidrug resistance. Moreover, the Warburg effect-targeted therapy has been testified to be feasible in inhibiting TNBC progression. However, not all TNBCs are sensitive to glycolysis inhibitors because TNBC cells flexibly switch their metabolic patterns to cope with different survival pressures, namely metabolic plasticity. Between the Warburg effect-targeted medicines and the actual curative effect, metabolic plasticity creates a divide that must be continuously researched and bridged.
引用
收藏
页数:15
相关论文
共 185 条
  • [21] Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
    Chang, Chih-Hao
    Qiu, Jing
    O'Sullivan, David
    Buck, Michael D.
    Noguchi, Takuro
    Curtis, Jonathan D.
    Chen, Qiongyu
    Gindin, Mariel
    Gubin, Matthew M.
    van der Windt, Gerritje J. W.
    Tonc, Elena
    Schreiber, Robert D.
    Pearce, Edward J.
    Pearce, Erika L.
    [J]. CELL, 2015, 162 (06) : 1229 - 1241
  • [22] Interplay between desmoglein2 and hypoxia controls metastasis in breast cancer
    Chang, Po-Hao
    Chen, Min-Che
    Tsai, Ya-Ping
    Tan, Grace Y. T.
    Hsu, Pang-Hung
    Jeng, Yung-Ming
    Tsai, Yi-Fang
    Yang, Muh-Hwa
    Hwang-Verslues, Wendy W.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (03)
  • [23] Warburg Effect Is a Cancer Immune Evasion Mechanism Against Macrophage Immunosurveillance
    Chen, Jing
    Cao, Xu
    Li, Bolei
    Zhao, Zhangchen
    Chen, Siqi
    Lai, Seigmund W. T.
    Muend, Sabina A.
    Nossa, Gianna K.
    Wang, Lei
    Guo, Weihua
    Ye, Jian
    Lee, Peter P.
    Feng, Mingye
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 11
  • [24] Autophagy Inhibition Augments the Anticancer Effects of Epirubicin Treatment in Anthracycline-Sensitive and -Resistant Triple-Negative Breast Cancer
    Chittaranjan, Suganthi
    Bortnik, Svetlana
    Dragowska, Wieslawa H.
    Xu, Jing
    Abeysundara, Namal
    Leung, Amy
    Go, Nancy E.
    DeVorkin, Lindsay
    Weppler, Sherry A.
    Gelmon, Karen
    Yapp, Donald T.
    Bally, Marcel B.
    Gorski, Sharon M.
    [J]. CLINICAL CANCER RESEARCH, 2014, 20 (12) : 3159 - 3173
  • [25] Breast Cancer Subtypes Underlying EMT-Mediated Catabolic Metabolism
    Cho, Eunae Sandra
    Kim, Nam Hee
    Yun, Jun Seop
    Cho, Sue Bean
    Kim, Hyun Sil
    Yook, Jong In
    [J]. CELLS, 2020, 9 (09) : 1 - 13
  • [26] Tumour acidosis: from the passenger to the driver's seat
    Corbet, Cyril
    Feron, Olivier
    [J]. NATURE REVIEWS CANCER, 2017, 17 (10) : 577 - 593
  • [27] The matrix in cancer
    Cox, Thomas R.
    [J]. NATURE REVIEWS CANCER, 2021, 21 (04) : 217 - 238
  • [28] Mitochondrial copper depletion suppresses triple-negative breast cancer in mice
    Cui, Liyang
    Gouw, Arvin M.
    LaGory, Edward L.
    Guo, Shenghao
    Attarwala, Nabeel
    Tang, Yao
    Qi, Ji
    Chen, Yun-Sheng
    Gao, Zhou
    Casey, Kerriann M.
    Bazhin, Arkadiy A.
    Chen, Min
    Hu, Leeann
    Xie, Jinghang
    Fang, Mingxi
    Zhang, Cissy
    Zhu, Qihua
    Wang, Zhiyuan
    Giaccia, Amato J.
    Gambhir, Sanjiv Sam
    Zhu, Weiping
    Felsher, Dean W.
    Pegram, Mark D.
    Goun, Elena A.
    Le, Anne
    Rao, Jianghong
    [J]. NATURE BIOTECHNOLOGY, 2021, 39 (03) : 357 - 367
  • [29] The harsh microenvironment in early breast cancer selects for a Warburg phenotype
    Damaghi, Mehdi
    West, Jeffrey
    Robertson-Tessi, Mark
    Xu, Liping
    Ferrall-Fairbanks, Meghan C.
    Stewart, Paul A.
    Persi, Erez
    Fridley, Brooke L.
    Altrock, Philipp M.
    Gatenby, Robert A.
    Sims, Peter A.
    Anderson, Alexander R. A.
    Gillies, Robert J.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (03)
  • [30] Oncometabolites in cancer aggressiveness and tumour repopulation
    Dando, Ilaria
    Dalla Pozza, Elisa
    Ambrosini, Giulia
    Torrens-Mas, Margalida
    Butera, Giovanna
    Mullappilly, Nidula
    Pacchiana, Raffaella
    Palmieri, Marta
    Donadelli, Massimo
    [J]. BIOLOGICAL REVIEWS, 2019, 94 (04) : 1530 - 1546